This edition contains the following:

This edition contains the following: New Adult Hep B Vaccine Approved! Treatment for Refractory Post-Transplant CMV Infection Now Available Alcohol Related Liver Disease in Women Liver Spot: Hepatitis D Meet

This edition contains the following: TLI Welcomes Dr. Rita Lepe, Director of Hepatology Health Disparities Studies Hispanics and Liver Disease So Close But Yet So Far…Promising Drugs That Came Up

This edition contains the following: First FDA-Approved NASH Drug Expected in 2020: Quick Facts to Know The Tussle Between Resection and Liver Transplantation in the Treatment of HCC “What advice

This edition contains the following: Living Donor Liver Transplantation An Update on Nonalcoholic Steatohepatitis (NASH) from the International Liver Congress Does direct-acting antiviral exposure affect hepatocellular carcinoma recurrence in patients

This edition contains the following: A New First-Line Oral Treatment for Advanced Hepatocellular Carcinoma Comprehensive, Cutting-Edge Care at The Texas Liver Tumor Center An Update on the Management of Severe

This edition contains the following: Autoimmune Hepatitis: Current And Future Treatment Options Cholangiocarcinoma: Diagnosis And Management Is Green Tea Good For Your Health? What Noninvasive Imaging Techniques Can Measure Liver

This edition contains the following: New Targeted Therapy for HCC Can my patients take over-the-counter herbal and dietary supplements? NAFLD/NASH Update

This edition contains the following: TLI Welcomes Dr. Fabian Rodas Opening of Texas Liver Tumor Center (TLTC) HCC in South Texas Latinos: Is Aflatoxin Exposure Partly to Blame? A Focus on Benign

This edition contains the following: Dr. Naim Alkhouri, Joins Texas Liver Institute and UT Health Oral Nutrition Supplement for a Patient with Cirrhosis How to Make Low Sodium Diet Appealing to Patients Hepatitis